B
BOTANIX PHARMACEUTICALS LTD
ASX: BOT (BOTANIX FPO [BOT])
Last update: 15 hours ago0.145
-0.01 (-6.45%)
| Previous Close | 0.155 |
| Open | 0.150 |
| Volume | 16,345,517 |
| Avg. Volume (3M) | 8,802,220 |
| Market Cap | 285,745,696 |
| Price / Sales | 52.88 |
| Price / Book | 3.98 |
| 52 Weeks Range | |
| Earnings Date | 29 Jul 2025 - 4 Aug 2025 |
| Operating Margin (TTM) | -8,467.07% |
| Diluted EPS (TTM) | -0.020 |
| Quarterly Revenue Growth (YOY) | -0.10% |
| Total Debt/Equity (MRQ) | 0.94% |
| Current Ratio (MRQ) | 10.63 |
| Operating Cash Flow (TTM) | -34.93 M |
| Levered Free Cash Flow (TTM) | -26.79 M |
| Return on Assets (TTM) | -34.35% |
| Return on Equity (TTM) | -56.99% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (AU) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Mixed | |
| Stock | BOTANIX FPO [BOT] | - | - |
AIStockmoo Score
2.1
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 4.5 |
| Technical Moving Averages | 3.5 |
| Technical Oscillators | 0.5 |
| Average | 2.13 |
|
Botanix Pharmaceuticals Ltd is a dermatology company. The company focuses on developing safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1204 - Atopic Dermatitis, and BTX 1702 - Rosacea, Sofdra - Axillary Hyperhidrosis, and others. The majority of Revenue is Derived from Australia. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| % Held by Insiders | 12.29% |
| % Held by Institutions | 23.43% |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |